Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

91.7%
Female
8.3%
Male

Age Information

The average age of patients reporting adverse events with BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS is 66.0 years.

Geographic Distribution

The majority of adverse event reports for BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS originate from CA.

Report Summary & Outcomes

176
Total Reports
176
As Primary/Secondary Suspect
0
Deaths Reported
110
Hospitalizations
1
Disabilities

Reporting Timeline

First adverse event report: 2003. Most recent report: 20201101. View full timeline →

More About BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS

BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS Full Profile Reports by Year Drug Interactions